Professor Monica Lahra

George CRR; Jeffery HE; Lahra MM, 2022, 'Infection of Mother and Baby', in Keeling's Fetal and Neonatal Pathology, Springer International Publishing, pp. 207 - 245, http://dx.doi.org/10.1007/978-3-030-84168-3_9

George CRR; Smith HV; Lahra MM, 2022, 'Neisseria meningitidis', in Molecular Typing in Bacterial Infections, Volume I, Springer International Publishing, pp. 85 - 99, http://dx.doi.org/10.1007/978-3-030-74018-4_3

Goire N; Speers DJ; Lahra MM; Whiley DM, 2016, 'Neisseria gonorrhoeae: The Pathogen, Diagnosis, and Antimicrobial Resistance', in Singh SK (ed.), HUMAN EMERGING AND RE-EMERGING INFECTIONS: VIRAL AND PARASITIC INFECTIONS, VOL 1, JOHN WILEY & SONS INC, pp. 683 - 697, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000470861900038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

George CRR; Lahra MM; Jeffery HE, 2015, 'The impact of infection during pregnancy on the mother and baby', in Keeling's Fetal and Neonatal Pathology, pp. 219 - 256, http://dx.doi.org/10.1007/978-3-319-19207-9_9

Jeffery HE; Lahra MM, 2007, 'The Impact of Infection During Pregnancy on the Mother and Baby', in Fetal and Neonatal Pathology, Springer London, pp. 379 - 423, http://dx.doi.org/10.1007/978-1-84628-743-5_16

Ayfan AKS; Macdonald J; Irwin AD; Zowawi HM; Forde BM; Paterson DL; Lahra MM; Whiley DM, 2022, 'Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, http://dx.doi.org/10.1093/jac/dkac242

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2022, 'Predisposing factors, microbiological features and outcomes of patients with clinical presumed concomitant microbial and herpes simplex keratitis', Eye (Basingstoke), vol. 36, pp. 86 - 94, http://dx.doi.org/10.1038/s41433-021-01440-1

George CR; Booy R; Nissen MD; Lahra MM, 2022, 'The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook', Medical Journal of Australia, vol. 216, pp. 504 - 507, http://dx.doi.org/10.5694/mja2.51463

Hui BB; Padeniya TN; Rebuli N; Gray RT; Wood JG; Donovan B; Duan Q; Guy R; Hocking JS; Lahra MM; Lewis DA; Whiley DM; Regan DG; Seib KL, 2022, 'A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection among Urban Men Who Have Sex with Men', Journal of Infectious Diseases, vol. 225, pp. 983 - 993, http://dx.doi.org/10.1093/infdis/jiab581

Lahra MM; George CR; Hogan TR, 2022, 'Australian Meningococcal Surveillance Programme Annual Report, 2021', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.46

Lahra MM; Hogan TR; Armstrong BH, 2022, 'Australian Gonococcal Surveillance Programme Annual Report, 2021', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.52

Lahra MM; Ray S; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2022', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.56

Lahra MM; Ray S; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2022', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.36

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2021', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.19

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2021', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.43

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2021', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.21

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2021', Communicable diseases intelligence (2018), vol. 46, http://dx.doi.org/10.33321/cdi.2022.46.1

Tickner JA; Lahra MM; Whiley DM, 2022, 'The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae', The Lancet Infectious Diseases, vol. 22, pp. 1271 - 1272, http://dx.doi.org/10.1016/S1473-3099(22)00520-5

Armstrong BH; Limnios A; Lewis DA; Hogan T; Kundu R; Ray S; Shoushtari M; El Nasser J; Driscoll T; Lahra MM, 2021, 'Is gentamicin a viable therapeutic option for treating resistant Neisseria gonorrhoeae in New South Wales?', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.12

Duan Q; Carmody C; Donovan B; Guy RJ; Hui BB; Kaldor JM; Lahra MM; Law MG; Lewis DA; Maley M; McGregor S; McNulty A; Selvey C; Templeton DJ; Whiley DM; Regan DG; Wood JG, 2021, 'Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia', PLoS Computational Biology, vol. 17, http://dx.doi.org/10.1371/journal.pcbi.1009385

Lahra MM; George CRR; Shoushtari M; Hogan TR, 2021, 'Australian Meningococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.46

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', COMMUNICABLE DISEASES INTELLIGENCE, vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.24

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.24

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.58

Lahra MM; Shoushtari M; Hogan T, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2021', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.63

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2021', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.68

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 October to 31 December 2020', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.44

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2021', Communicable diseases intelligence (2018), vol. 45, pp. E447

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Communicable Diseases Intelligence', COMMUNICABLE DISEASES INTELLIGENCE, vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.47

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2021', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.45

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2020', Communicable diseases intelligence (2018), vol. 45, http://dx.doi.org/10.33321/cdi.2021.45.36

Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2021, 'Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18', Journal of Antimicrobial Chemotherapy, vol. 76, pp. 1815 - 1821, http://dx.doi.org/10.1093/jac/dkab099

Trembizki E; Jennison AV; Buckley C; Bright A; Holds J; Ward A; Pitt J; Pendle S; Baird R; Freeman K; Robson J; Mhango L; Lowry K; Lahra M; Whiley D, 2021, 'Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia', Journal of Antimicrobial Chemotherapy, vol. 76, pp. 270 - 271, http://dx.doi.org/10.1093/JAC/DKAA402

Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JAR; Galas M; Ramon-Pardo P; Weinstock H; Wi T, 2021, 'WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study', The Lancet Microbe, vol. 2, pp. e627 - e636, http://dx.doi.org/10.1016/S2666-5247(21)00171-3

Badahdah AM; Bakarman MA; Khatami A; Tashani M; Barasheed O; Alfelali M; Azeem MI; Bokhary H; Soltan O; Lahra MM; Jeoffreys N; Kok J; Dwyer DE; Booy R; Rashid H, 2020, 'Meningococcal and pneumococcal carriage in Hajj pilgrims: Findings of a randomized controlled trial', Journal of Travel Medicine, vol. 27, http://dx.doi.org/10.1093/JTM/TAAA032

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2020, 'Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia', Clinical and Experimental Ophthalmology, vol. 48, pp. 183 - 191, http://dx.doi.org/10.1111/ceo.13672

Cabrera-Aguas M; Khoo P; Lahra MM; Watson SL, 2020, 'Travel associated microbial keratitis: is resistance a risk?', Travel Medicine and Infectious Disease, vol. 38, http://dx.doi.org/10.1016/j.tmaid.2020.101903

Ferreyra C; Osborn J; Moussy F; Alirol E; Lahra M; Whiley D; Shafer W; Unemo M; Klausner J; Cirino CK; Wi T, 2020, 'Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus', PLoS ONE, vol. 15, http://dx.doi.org/10.1371/journal.pone.0237424

Fifer H; Hughes G; Whiley D; Lahra MM, 2020, 'Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia', The Lancet Infectious Diseases, vol. 20, pp. 276 - 278, http://dx.doi.org/10.1016/S1473-3099(20)30055-4

George CRR; Kundu RL; Whiley DM; Lahra MM, 2020, 'Are sex norms the norm in gonococcal surveillance?', The Lancet Microbe, vol. 1, pp. e143 - e144, http://dx.doi.org/10.1016/S2666-5247(20)30087-2

Gilbey T; McIver C; Brandenburg U; Goeman E; Polkinghorne A; Lahra M; Branley J, 2020, 'Suspected materno-fetal transmission of neisseria meningitidis serogroup w clonal complex 11 causing early- onset neonatal sepsis', Open Forum Infectious Diseases, vol. 7, http://dx.doi.org/10.1093/ofid/ofaa039

Hepschke JL; Ung L; Cabrera-Aguas M; Ross C; Kumar N; Lahra MM; Watson S, 2020, 'Pediatric Microbial Keratitis: Experience from Tertiary Referral Centers in New South Wales, Australia', Pediatric Infectious Disease Journal, pp. 883 - 888, http://dx.doi.org/10.1097/INF.0000000000002723

Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2020, 'Laboratory-based surveillance of clostridium difficile infection in australian health care and community settings, 2013 to 2018', Journal of Clinical Microbiology, vol. 58, http://dx.doi.org/10.1128/JCM.01552-20

Khoo P; Cabrera-Aguas MP; Nguyen V; Lahra MM; Watson SL, 2020, 'Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation', Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 258, pp. 1745 - 1755, http://dx.doi.org/10.1007/s00417-020-04681-0

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2017', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2019.44.7

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 January to 31 March 2017', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2019.44.8

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 January to 31 March 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.3

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 July to 30 September 2017', COMMUNICABLE DISEASES INTELLIGENCE, vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.6

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 July to 30 September 2017', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2019.44.6

Lahra MM; Enriquez RP, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.9

Lahra MM; Enriquez RP; George CRR, 2020, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2018', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.5

Lahra MM; Enriquez RP; George CRR, 2020, 'Australian Gonococcal Surveillance Programme Annual Report, 2018', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.4

Lahra MM; Enriquez RP; Hogan TP, 2020, 'Australian Meningococcal Surveillance Programme annual report, 2018', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.10

Lahra MM; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.37

Lahra MM; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme: 1 July to 30 September 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.73

Lahra MM; Hogan TR, 2020, 'Australian Meningococcal Surveillance Programme annual report, 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.62

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.47

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.50

Lahra MM; Shoushtari M; George CRR; Armstrong BH; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme Annual Report, 2019', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.58

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme 1 July to 30 September 2020', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.96

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2020', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.61

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme: 1 April to 30 June 2020', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.74

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2020', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.65

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2020', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.95

Lahra MM; Shoushtari M; Ray S, 2020, 'Meningococcal Surveillance Australia Reporting period 1 April to 30 June 2020', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.81

Watson SL; Cabrera-Aguas M; Keay L; Khoo P; McCall D; Lahra MM, 2020, 'The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia', Mycoses, vol. 63, pp. 43 - 51, http://dx.doi.org/10.1111/myc.13009

Watson SL; Gatus BJ; Cabrera-Aguas M; Armstrong BH; George CR; Khoo P; Lahra MM, 2020, 'Bacterial Ocular Surveillance System (BOSS) Sydney, Australia 2017-2018', Communicable diseases intelligence (2018), vol. 44, http://dx.doi.org/10.33321/cdi.2020.44.86

Buckley C; Beatson SA; Limnios A; Lahra MM; Whiley DM; Forde BM, 2019, 'Whole-genome sequencing as an improved means of investigating Neisseria gonorrhoeae treatment failures', Sexual Health, vol. 16, pp. 500 - 507, http://dx.doi.org/10.1071/SH19012

Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D, 2019, 'Evaluation of the ResistancePlus GC (beta) assay: A commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae', Journal of Antimicrobial Chemotherapy, vol. 74, pp. 1820 - 1824, http://dx.doi.org/10.1093/jac/dkz108

George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo Y-R; Ishikawa N; Wi T; Lahra MM, 2019, 'Systematic review and survey of neisseria gonorrhoeae antimicrobial resistance data in the Asia Pacific, 2011 to 2016', Pathology, vol. 51, pp. S136 - S136, http://dx.doi.org/10.1016/j.pathol.2018.12.395

George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo YR; Ishikawa N; Wi T; Lahra MM, 2019, 'Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016', PLoS ONE, vol. 14, http://dx.doi.org/10.1371/journal.pone.0213312

Hanrahan JK; Hogan TR; Buckley C; Trembizki E; Mitchell H; Lau CL; Whiley DM; Lahra MM, 2019, 'Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history', Journal of Antimicrobial Chemotherapy, vol. 74, pp. 2214 - 2219, http://dx.doi.org/10.1093/jac/dkz182

Jennison AV; Whiley D; Lahra MM; Graham RM; Cole MJ; Hughes G; Fifer H; Andersson M; Edwards A; Eyre D, 2019, 'Genetic relatedness of ceftriaxone-resistant and highlevel azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018', Eurosurveillance, vol. 24, http://dx.doi.org/10.2807/1560-7917.ES.2019.24.8.1900118

Khoo P; Cabrera-Aguas M; Robaei D; Lahra MM; Watson S, 2019, 'Microbial Keratitis and Ocular Surface Disease: A 5-Year Study of the Microbiology, Risk Factors and Clinical Outcomes in Sydney, Australia', Current Eye Research, vol. 44, pp. 1195 - 1202, http://dx.doi.org/10.1080/02713683.2019.1631852

Kiatchoosakun P; Jirapradittha J; Sirikarn P; Laopaiboon M; Pattanittum P; Chandrakachorn W; Srirojana S; Jeffery H; Green S; Lumbiganon P; Green S; Jeffery H; Osborne D; Lahra M; McKenzie J; Laopaiboon M; Lumbiganon P; McDonald S; Crowther C; Ho J; Mantaring J; Van Rostenberghe H; Wandita S; Rohsiswatmo R; Hassan H; Bautisa R, 2019, 'Early-Onset Neonatal Sepsis and Antibiotic Use in Northeast Thailand', AMERICAN JOURNAL OF PERINATOLOGY, vol. 36, pp. 1295 - 1303, http://dx.doi.org/10.1055/s-0038-1676829

Lahra MM; Enriquez R; George CRR, 2019, 'Australian Gonococcal Surveillance Programme Annual Report, 2017', Communicable diseases intelligence (2018), vol. 43, http://dx.doi.org/10.33321/cdi.2019.43.13

Lahra MM; Enriquez RP, 2019, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2017.', Commun Dis Intell (2018), vol. 43, http://dx.doi.org/10.33321/cdi.2019.43.62

Roczo-Farkas S; Cowley D; Bines JE; Bradbury S; Malinsky E; Rawlinson W; Lahra M; Merif J; Kesson A; Tam I; Sintchenko V; Olna T; Givney R; Pearce S; Delves K; Spence D; Wehrhahn M; Karimi M; Cook H; Moore F; McMahon J; Nimmo G; Bletchly C; George N; Lambert S; Dang L; Gilmore G; Higgins G; Schepetiuk S; Williamson J; Buttery J; Kotsanas D; Adamopolous P; Hrysoudis E; Gray F; Quach R; Smith D; Levy A; Lang J, 2019, 'Australian Rotavirus Surveillance Program : Annual Report, 2017', COMMUNICABLE DISEASES INTELLIGENCE, vol. 43, http://dx.doi.org/10.33321/cdi.2019.43.28

Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JAR; Ramon-Pardo P; Bolan G; Wi T, 2019, 'World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts', Sexual Health, vol. 16, pp. 412 - 425, http://dx.doi.org/10.1071/SH19023

Yeo KT; Lahra M; Bajuk B; Hilder L; Abdel-Latif ME; Wright IM; Oei JL, 2019, 'Long-term outcomes after group B streptococcus infection: A cohort study', Archives of Disease in Childhood, vol. 104, pp. 172 - 178, http://dx.doi.org/10.1136/archdischild-2017-314642

Buckley C; Forde BM; Trembizki E; Lahra MM; Beatson SA; Whiley DM, 2018, 'Use of whole genome sequencing to investigate an increase in Neisseria gonorrhoeae infection among women in urban areas of Australia', Scientific Reports, vol. 8, http://dx.doi.org/10.1038/s41598-018-20015-x

George CRR; Rockett R; Whiley DM; Enriquez RP; Kundu R; El-Nasser J; Sintchenko V; Lahra MM, 2018, 'Whole genome sequencing to characterise azithromycin resistant Neisseria gonorrhoeae from New South Wales in 2017', Pathology, vol. 50, pp. S51 - S51, http://dx.doi.org/10.1016/j.pathol.2017.12.117

Lahra MM; Enriquez R, 2018, 'Australian Gonococcal Surveillance Programme Annual Report, 2016', Communicable diseases intelligence (2018), vol. 42

Lahra MM; Martin I; Demczuk W; Jennison AV; Lee KI; Nakayama SI; Lefebvre B; Longtin J; Ward A; Mulvey MR; Wi T; Ohnishi M; Whiley D, 2018, 'Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain', Emerging Infectious Diseases, vol. 24, pp. 735 - 740, http://dx.doi.org/10.3201/eid2404.171873

Regan DG; Hui BB; Wood JG; Fifer H; Lahra MM; Whiley DM, 2018, 'Treatment for pharyngeal gonorrhoea under threat', The Lancet Infectious Diseases, vol. 18, pp. 1175 - 1177, http://dx.doi.org/10.1016/S1473-3099(18)30610-8

Watson S; Cabrera-Aguas M; Khoo P; Pratama R; Gatus BJ; Gulholm T; El-Nasser J; Lahra MM, 2018, 'Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 Annual Report', Clinical and Experimental Ophthalmology, vol. 47, pp. 20 - 25, http://dx.doi.org/10.1111/ceo.13364

Whiley DM; Jennison A; Pearson J; Lahra MM, 2018, 'Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin', The Lancet Infectious Diseases, vol. 18, pp. 717 - 718, http://dx.doi.org/10.1016/S1473-3099(18)30340-2

Whiley DM; Kundu RL; Jennison AV; Buckley C; Limnios A; Hogan T; Enriquez R; El Nasser J; Robert George C; Lahra MM, 2018, 'Azithromycin-resistant Neisseria gonorrhoeae spreading amongst men who have sex with men (MSM) and heterosexuals in New South Wales, Australia, 2017', Journal of Antimicrobial Chemotherapy, vol. 73, pp. 1242 - 1246, http://dx.doi.org/10.1093/jac/dky017

Whiley DM; Mhango L; Jennison AV; Nimmo G; Lahra MM, 2018, 'Direct detection of penA gene associated with ceftriaxone-resistant neisseria gonorrhoeae FC428 strain by using PCR', Emerging Infectious Diseases, vol. 24, pp. 1573 - 1575, http://dx.doi.org/10.3201/eid2408.180295

Alirol E; Wi TE; Bala M; Bazzo ML; Chen XS; Deal C; Dillon JAR; Kularatne R; Heim J; Hooft van Huijsduijnen R; Hook EW; Lahra MM; Lewis DA; Ndowa F; Shafer WM; Tayler L; Workowski K; Unemo M; Balasegaram M, 2017, 'Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines', PLoS Medicine, vol. 14, http://dx.doi.org/10.1371/journal.pmed.1002366

Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB; Nissen M; Campbell-Lloyd S; Peterson K; Koehler A; Leask J, 2017, 'Epidemiology of invasive meningococcal b disease in Australia, 1999-2015: Priority populations for vaccination', Medical Journal of Australia, vol. 207, pp. 382 - 387, http://dx.doi.org/10.5694/mja16.01340

Bartlett AW; Smith B; George CRR; McMullan B; Kesson A; Lahra MM; Palasanthiran P, 2017, 'Epidemiology of Late and Very Late Onset Group B Streptococcal Disease: Fifteen-Year Experience from Two Australian Tertiary Pediatric Facilities', Pediatric Infectious Disease Journal, vol. 36, pp. 20 - 24, http://dx.doi.org/10.1097/INF.0000000000001345

Goire N; Kundu R; Trembizki E; Buckley C; Hogan TR; Lewis DA; Branley JM; Whiley DM; Lahra MM, 2017, 'Mixed gonococcal infections and antimicrobial resistance surveillance', Pathology, vol. 49, pp. S115 - S115, http://dx.doi.org/10.1016/j.pathol.2016.12.337

Goire N; Kundu R; Trembizki E; Buckley C; Hogan TR; Lewis DA; Branley JM; Whiley DM; Lahra MM, 2017, 'Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: Implications for antimicrobial resistance surveillance?', Journal of Antimicrobial Chemotherapy, vol. 72, pp. 407 - 409, http://dx.doi.org/10.1093/jac/dkw406

Lahra MM, 2017, 'Antimicrobial resistance in Neisseria gonorrhoeae in Australia', Pathology, vol. 49, pp. S51 - S51, http://dx.doi.org/10.1016/j.pathol.2016.12.123

Lahra MM, 2017, 'Australian Meningococcal Surveillance Programme, 1 January to 31 March 2017', Communicable diseases intelligence quarterly report, vol. 41, pp. E201

Lahra MM; Enriquez R, 2017, 'Australian Meningococcal Surveillance Programme annual report, 2016', Communicable diseases intelligence quarterly report, vol. 41, pp. E369 - E382

Lahra MM; Enriquez R, 2017, 'Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017', Communicable diseases intelligence quarterly report, vol. 41, pp. E241 - E242

Lahra MM; Enriquez R, 2017, 'MENINGOCOCCAL SURVEILLANCE AUSTRALIA REPORTING PERIOD 1 APRIL TO 30 JUNE 2017', COMMUNICABLE DISEASES INTELLIGENCE, vol. 41, pp. E241 - E242, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423988300009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM; Enriquez RP, 2017, 'Australian Gonococcal Surveillance Programme annual report, 2015', Communicable diseases intelligence quarterly report, vol. 41

Lahra MM; George CRR; Whiley DM, 2017, 'The Australian Gonococcal Surveillance Programme 1979-2017', MICROBIOLOGY AUSTRALIA, vol. 38, pp. 175 - 179, http://dx.doi.org/10.1071/MA17062

Lahra MM; Trembizki E; Buckley C; Donovan B; Chen M; Guy R; Kundu RL; Regan DG; Whiley DM, 2017, 'Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes', Journal of Antimicrobial Chemotherapy, vol. 72, pp. 705 - 711, http://dx.doi.org/10.1093/jac/dkw452

Lahra MM; Ward A; Trembizki E; Hermanson J; Clements E; Lawrence A; Whiley D, 2017, 'Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia', The Lancet Infectious Diseases, vol. 17, pp. 133 - 134, http://dx.doi.org/10.1016/S1473-3099(17)30007-5

Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM, 2017, 'Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae, Northern Territory, Australia', Emerging Infectious Diseases, vol. 23, pp. 1478 - 1485, http://dx.doi.org/10.3201/eid2309.170427

Wi T; Lahra MM; Ndowa F; Bala M; Dillon JAR; Ramon-Pardo P; Eremin SR; Bolan G; Unemo M, 2017, 'Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action', PLoS Medicine, vol. 14, http://dx.doi.org/10.1371/journal.pmed.1002344

Buckley C; Trembizki E; Donovan B; Chen M; Freeman K; Guy R; Kundu R; Lahra MM; Regan DG; Smith H; Whiley DM; Nimmo G; Bletchly C; Baird R; Hicks V; Hogan T, 2016, 'A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 353 - 356, http://dx.doi.org/10.1093/jac/dkv366

Buckley C; Trembizki E; Donovan B; Chen M; Freeman K; Guy R; Lahra MM; Kundu RL; Regan DG; Smith HV; Whiley DM; Kaldor J; Wand H; Ward J; Fairley C; Ryder N; Su JY, 2016, 'Real-time PCR detection of Neisseria gonorrhoeae susceptibility to penicillin', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 3090 - 3095, http://dx.doi.org/10.1093/jac/dkw291

Enriquez RP; Goire N; Kundu R; Gatus BJ; Lahra MM, 2016, 'A comparison of agar dilution with the Calibrated Dichotomous Sensitivity (CDS) and Etest methods for determining the minimum inhibitory concentration of ceftriaxone against Neisseria gonorrhoeae', Diagnostic Microbiology and Infectious Disease, vol. 86, pp. 40 - 43, http://dx.doi.org/10.1016/j.diagmicrobio.2016.04.016

Hui BB; Whiley DM; Donovan B; Law MG; Regan DG; Chen M; Guy R; Lahra M, 2016, 'Identifying factors that lead to the persistence of imported gonorrhoeae strains: A modelling study', Sexually Transmitted Infections, vol. 93, pp. 221 - 225, http://dx.doi.org/10.1136/sextrans-2016-052738

Lahra MM; Dillon JAR; George CRR; Lewis DA; Wi TE; Whiley DM, 2016, 'From zero to zero in 100 years: Gonococcal antimicrobial resistance', Microbiology Today, vol. 43, pp. 173 - 175, http://dx.doi.org/10.1071/MA16058

Lahra MM; Enriquez RP, 2016, 'AUSTRALIAN MENINGOCOCCAL SURVEILLANCE PROGRAMMMME, 1 APRIL TO 30 JUNE 2016', COMMUNICABLE DISEASES INTELLIGENCE, vol. 40, pp. E447 - E447, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388538500018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM; Enriquez RP, 2016, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2016', Communicable diseases intelligence quarterly report, vol. 40, pp. E557 - E559

Lahra MM; Enriquez RP, 2016, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2016', Communicable diseases intelligence quarterly report, vol. 40, pp. E554 - E556

Lahra MM; Enriquez RP, 2016, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015', Communicable diseases intelligence quarterly report, vol. 40, pp. E179 - E181

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme annual report, 2014', Communicable diseases intelligence quarterly report, vol. 40, pp. E221 - E228

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme annual report, 2015', Communicable diseases intelligence quarterly report, vol. 40, pp. E503 - E511

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme, 1 January to 31 March 2016', Communicable diseases intelligence quarterly report, vol. 40, pp. E446

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme, 1 July to 30 September 2016', Communicable diseases intelligence quarterly report, vol. 40, pp. E560

Lawrence GL; Wang H; Lahra M; Booy R; McIntyre PB, 2016, 'Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme', Epidemiology and Infection, vol. 144, pp. 2382 - 2391, http://dx.doi.org/10.1017/S0950268816000704

Martin NV; Ong KS; Howden BP; Lahra MM; Lambert SB; Beard FH; Dowse GK; Saul N, 2016, 'Rise in invasive serogroup W meningococcal disease in Australia 2013-2015', Communicable diseases intelligence quarterly report, vol. 40, pp. E454 - E459

Pillay A; Katz SS; Abrams AJ; Ballard RC; Simpson SV; Taleo F; Lahra MM; Batra D; Rowe L; Trees DL; Asiedu K; Chen CY, 2016, 'Complete genome sequences of 11 Haemophilus ducreyi isolates from children with cutaneous lesions in Vanuatu and Ghana', Genome Announcements, vol. 4, http://dx.doi.org/10.1128/genomeA.00459-16

Trembizki E; Guy R; Donovan B; Kaldor JM; Lahra MM; Whiley DM, 2016, 'Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin', The Lancet Infectious Diseases, vol. 16, pp. 1005 - 1006, http://dx.doi.org/10.1016/S1473-3099(16)30271-7

Trembizki E; Wand H; Donovan B; Chen M; Fairley CK; Freeman K; Guy R; Kaldor JM; Lahra MM; Lawrence A; Lau C; Pearson J; Regan DG; Ryder N; Smith H; Stevens K; Su JY; Ward J; Whiley DM, 2016, 'The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia: A Nationwide Cross-Sectional Study, 2012', Clinical Infectious Diseases, vol. 63, pp. 1591 - 1598, http://dx.doi.org/10.1093/cid/ciw648

Unemo M; Golparian D; Sánchez-Busó L; Grad Y; Jacobsson S; Ohnishi M; Lahra MM; Limnios A; Sikora AE; Wi T; Harris SR, 2016, 'The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: Phenotypic, genetic and reference genome characterization', Journal of Antimicrobial Chemotherapy, vol. 71, pp. 3096 - 3108, http://dx.doi.org/10.1093/jac/dkw288

Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY, 2015, 'Persistence of neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection', Clinical Infectious Diseases, vol. 60, pp. 557 - 563, http://dx.doi.org/10.1093/cid/ciu873

Bissessor M; Whiley DM; Lee DM; Snow AF; Fairley CK; Peel J; Bradshaw CS; Hocking JS; Lahra MM; Chen MY, 2015, 'Detection of neisseria gonorrhoeae isolates from tonsils and posterior oropharynx', Journal of Clinical Microbiology, vol. 53, pp. 3624 - 3626, http://dx.doi.org/10.1128/JCM.01647-15

Buckley C; Trembizki E; Baird RW; Chen M; Donovan B; Freeman K; Goire N; Guy R; Lahra MM; Regan D; Whiley DM, 2015, 'Multitarget PCR assay for direct detection of penicillinase-producing neisseria gonorrhoeae for enhanced surveillance of gonococcal antimicrobial resistance', Journal of Clinical Microbiology, vol. 53, pp. 2706 - 2708, http://dx.doi.org/10.1128/JCM.00540-15

Hui BB; Ryder N; Su JY; Ward J; Chen MY; Donovan B; Fairley CK; Guy RJ; Lahra MM; Law MG; Whiley DM; Regan DG, 2015, 'Exploring the benefits of molecular testing for gonorrhoea antibiotic resistance surveillance in remote settings', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0133202

Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ, 2015, 'A signal-to-cutoff ratio in the abbott architect HIV Ag/Ab combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting', Journal of Clinical Microbiology, vol. 53, pp. 1709 - 1711, http://dx.doi.org/10.1128/JCM.03583-14

Lahra MM, 2015, 'Australian Gonococcal Surveillance Programme annual report, 2013', Communicable diseases intelligence quarterly report, vol. 39, pp. E137 - E145

Lahra MM, 2015, 'Australian Gonococcal Surveillance Programme annual report, 2014', Communicable diseases intelligence quarterly report, vol. 39, pp. E347 - E354

Lahra MM, 2015, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2014', Communicable diseases intelligence quarterly report, vol. 39, pp. E294 - E296

Lahra MM; Enriquez RP, 2015, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015', Communicable diseases intelligence quarterly report, vol. 39, pp. E628 - E630

Lahra MM; Enriquez RP, 2015, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2015', Communicable diseases intelligence quarterly report, vol. 39, pp. E297 - E298

Lahra MM; Enriquez RP, 2015, 'Australian Meningococcal Surveillance Programme, 1 July to 30 September 2015', Communicable diseases intelligence quarterly report, vol. 39, pp. E631

Lahra MM; Kundu R, 2015, 'Australian Meningococcal Surveillance Programme quarterly report, 1 April to 30 June 2015', Communicable diseases intelligence quarterly report, vol. 39, pp. E495

Lahra MM; Kundu R, 2015, 'Australian Meningococcal Surveillance Programme quarterly report, 1 January to 31 March 2015', Communicable diseases intelligence quarterly report, vol. 39, pp. E299

Lahra MM; Ryder N; While DM, 2015, 'A New Multidrug-Resistant Strain of Neisseria gonorrhoeae in Australia (vol 371, pg 1850, 2014)', NEW ENGLAND JOURNAL OF MEDICINE, vol. 373, pp. 982 - 982, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360439500027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Trembizki E; Buckley C; Donovan B; Chen M; Guy R; Kaldor J; Lahra MM; Regan DG; Smith H; Ward J; Whiley DM, 2015, 'Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance', The Journal of antimicrobial chemotherapy, vol. 70, pp. 3244 - 3249, http://dx.doi.org/10.1093/jac/dkv274

Trembizki E; Doyle C; Buckley C; Jennison A; Smith H; Bates J; Sloots T; Nissen M; Lahra MM; Whiley D, 2015, 'Estimating the prevalence of mixed-type gonococcal infections in Queensland, Australia', Sexual Health, vol. 12, pp. 439 - 444, http://dx.doi.org/10.1071/SH15009

Whiley DM; Lahra MM, 2015, 'Review of 2005 Public Health Laboratory Network Neisseria gonorrhoeae nucleic acid amplification tests guidelines', Communicable diseases intelligence quarterly report, vol. 39, pp. E42 - E45

Whiley DM; Lahra MM; Unemo M, 2015, 'Prospects of untreatable gonorrhea and ways forward', Future Microbiology, vol. 10, pp. 313 - 316, http://dx.doi.org/10.2217/FMB.14.138

Bourne C; Lahra MM; Donovan B, 2014, 'Gaining control of gonorrhoea', Medicine Today, vol. 15, pp. 58 - 60

Goire N; Lahra MM; Chen M; Donovan B; Fairley CK; Guy R; Kaldor J; Regan D; Ward J; Nissen MD; Sloots TP; Whiley DM, 2014, 'Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance', Nature Reviews Microbiology, vol. 12, pp. 223 - 229, http://dx.doi.org/10.1038/nrmicro3217

Lahra MM, 2014, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2014', Communicable diseases intelligence quarterly report, vol. 38, pp. E159 - E161

Lahra MM, 2014, 'Australian Meningococcal Surveillance Programme quarterly report, 1 April to 30 June 2014', Communicable diseases intelligence quarterly report, vol. 38, pp. E262

Lahra MM, 2014, 'Australian Meningococcal Surveillance Programme quarterly report, 1 January to 31 March 2014', Communicable diseases intelligence quarterly report, vol. 38, pp. E162

Lahra MM, 2014, 'Australian gonococcal surveillance programme, 1 April to 30 June 2014', Communicable diseases intelligence quarterly report, vol. 38, pp. E390 - E392

Lahra MM; Donovan B; Whiley DM, 2014, 'Decreased susceptibility to cephalosporins among gonococci?', The Lancet Infectious Diseases, vol. 14, pp. 186, http://dx.doi.org/10.1016/S1473-3099(14)70015-5

Lahra MM; Enriquez RP, 2014, 'Australian Meningococcal Surveillance Programme annual report, 2013', Communicable diseases intelligence quarterly report, vol. 38, pp. E301 - E308

Lahra MM; Enriquez RP, 2014, 'Meningococcal surveillance Australia, 1 July to 30 September 2014', Communicable diseases intelligence quarterly report, vol. 38, pp. E393

Lahra MM; Ryder N; Whiley DM, 2014, 'A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia', New England Journal of Medicine, vol. 371, pp. 1850 - 1851, http://dx.doi.org/10.1056/NEJMc1408109

Roberts-Witteveen A; Pennington K; Higgins N; Lang C; Lahra M; Waddell R; Kaldor J, 2014, 'Epidemiology of gonorrhoea notifications in Australia, 2007-12', Sexual Health, vol. 11, pp. 324 - 331, http://dx.doi.org/10.1071/SH13205

Stevens K; Zaia A; Tawil S; Bates J; Hicks V; Whiley D; Limnios A; Lahra MM; Howden BP, 2014, 'Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Australia', Journal of Antimicrobial Chemotherapy, vol. 70, pp. 1267 - 1268, http://dx.doi.org/10.1093/jac/dku490

Trembizki E; Buckley C; Lawrence A; Lahra M; Whiley D, 2014, 'Characterization of a novel Neisseria gonorrhoeae penicillinase-producing plasmid isolated in Australia in 2012', Antimicrobial Agents and Chemotherapy, vol. 58, pp. 4984 - 4985, http://dx.doi.org/10.1128/AAC.02993-14

Trembizki E; Doyle C; Jennison A; Smith H; Bates J; Lahra M; Whiley D, 2014, 'A Neisseria gonorrhoeae strain with a meningococcal mtrR sequence', Journal of Medical Microbiology, vol. 63, pp. 1113 - 1115, http://dx.doi.org/10.1099/jmm.0.074286-0

Trembizki E; Smith H; Lahra MM; Chen M; Donovan B; Fairley CK; Guy R; Kaldor J; Regan D; Ward J; Nissen MD; Sloots TP; Whiley DM, 2014, 'High-throughput informative single nucleotide polymorphism-based typing of Neisseria gonorrhoeae using the Sequenom MassARRAY iPLEX platform', Journal of Antimicrobial Chemotherapy, vol. 69, pp. 1526 - 1532, http://dx.doi.org/10.1093/jac/dkt544

Whiley D; Trembizki E; Buckley C; Freeman K; Lawrence A; Limnios A; Pearson J; Smith H; Stevens K; Lahra MM, 2014, 'Penicillinase-Producing Plasmid Types in Neisseria gonorrhoeae Clinical Isolates from Australia', ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 58, pp. 7576 - 7578, http://dx.doi.org/10.1128/AAC.04120-14

Esterman EE; Lahra MM; Zurynski YA; Booy R; Elliott EJ, 2013, 'Influenza infection in infants aged <6 months during the H1N1-09 pandemic: A hospital-based case series', Journal of Paediatrics and Child Health, vol. 49, pp. 635 - 640, http://dx.doi.org/10.1111/jpc.12266

Goire N; Lahra MM; Ohnishi M; Hogan T; Liminios AE; Nissen MD; Sloots TP; Whiley DM, 2013, 'Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain', EUROSURVEILLANCE, vol. 18, pp. 18 - 23, http://dx.doi.org/10.2807/1560-7917.ES2013.18.14.20444

Goire N; Lahra MM; Ohnishi M; Hogan T; Liminios AE; Nissen MD; Sloots TP; Whiley DM, 2013, 'Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain', Eurosurveillance, vol. 18, pp. 20444 - 20444, http://dx.doi.org/10.2807/1560-7917.ES2013.18.14.20444

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme annual report, 2012', Communicable diseases intelligence quarterly report, vol. 37, pp. E233 - E239

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2013', Communicable diseases intelligence quarterly report, vol. 37, pp. E280 - E281

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2013', Communicable diseases intelligence quarterly report, vol. 37, pp. E278 - E279

Lahra MM, 2013, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2013', Communicable diseases intelligence quarterly report, vol. 37, pp. E436 - E437

Lahra MM, 2013, 'Gonococcal surveillance Australia: quarter 3, 2012.', Communicable diseases intelligence quarterly report, vol. 37

Lahra MM; Enriquez R, 2013, 'Australian Meningococcal Surveillance Programme quarterly report, 1 April to 30 June 2013', Communicable diseases intelligence quarterly report, vol. 37, pp. E282

Lahra MM; Enriquez R, 2013, 'Australian Meningococcal Surveillance Programme, 1 July to 30 September 2013', Communicable diseases intelligence quarterly report, vol. 37, pp. E438

Lahra MM; Enriquez R, 2013, 'Meningococcal Surveillance Australia reporting period 1 January to 31 March 2013', Communicable diseases intelligence quarterly report, vol. 37, pp. E179

Lahra MM; Enriquez RP, 2013, 'Australian Meningococcal Surveillance Programme annual report, 2012', Communicable diseases intelligence quarterly report, vol. 37, pp. E224 - E232

Lahra MM; Lo YR; Whiley DM, 2013, 'Gonococcal antimicrobial resistance in the Western Pacific Region', Sexually Transmitted Infections, vol. 89, http://dx.doi.org/10.1136/sextrans-2012-050906

Lusk MJ; Uddin RNN; Lahra MM; Garden FL; Kundu RL; Konecny P, 2013, 'Pharyngeal Gonorrhoea in Women: An Important Reservoir for Increasing Neisseria gonorrhoea Prevalence in Urban Australian Heterosexuals?', J Sex Transm Dis, vol. 2013, pp. 967471, http://dx.doi.org/10.1155/2013/967471

Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM, 2013, 'One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia', Sexual Health, vol. 10, pp. 460 - 462, http://dx.doi.org/10.1071/SH13077

Tabrizi SN; Unemo M; Golparian D; Twin J; Limnios AE; Lahra M; Guy R, 2013, 'ANALYTICAL EVALUATION OF THE GENEXPERT (R) CT/NG, THE FIRST GENETIC POINT OF CARE ASSAY FOR SIMULTANEOUS DETECTION OF NEISSERIA GONORRHOEAE AND CHLAMYDIA TRACHOMATIS', SEXUALLY TRANSMITTED INFECTIONS, vol. 89, pp. A360 - A360, http://dx.doi.org/10.1136/sextrans-2013-051184.1125

Trembizki E; Lahra M; Stevens K; Freeman K; Hogan T; Hogg G; Lawrence A; Limnios A; Pearson J; Smith H; Nissen M; Sloots T; Whiley DM, 2013, 'A national quality assurance survey of Neisseria gonorrhoeae testing', Journal of Medical Microbiology, vol. 63, pp. 45 - 49, http://dx.doi.org/10.1099/jmm.0.065094-0

Whiley DM; Goire N; Rahimi F; Lahra MM; Limnios AE; Nissen MD; Sloots TP, 2013, 'Real-time PCR genotyping of Neisseria gonorrhoeae isolates using 14 informative single nucleotide polymorphisms on gonococcal housekeeping genes', Journal of Antimicrobial Chemotherapy, vol. 68, pp. 322 - 328, http://dx.doi.org/10.1093/jac/dks381

Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G, 2013, 'Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.', The Journal of antimicrobial chemotherapy, vol. 68, pp. 1445 - 1447, http://dx.doi.org/10.1093/jac/dkt017

BaAlawi F; Robertson PW; Lahra M; Rawlinson WD, 2012, 'Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primary CMV infection', Pathology, vol. 44, pp. 381 - 383, http://dx.doi.org/10.1097/PAT.0b013e328353bec0

Goire N; Freeman K; Lambert SB; Nimmo GR; Limnios AE; Lahra MM; Nissen MD; Sloots TP; Whiley DM, 2012, 'The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance', Sexual Health, vol. 9, pp. 422 - 429, http://dx.doi.org/10.1071/SH12026

Goire N; Ohnishi M; Limnios AE; Lahra MM; Lambert SB; Nimmo GR; Nissen MD; Sloots TP; Whiley DM, 2012, 'Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: A real-time pcr assay for direct detection of the neisseria gonorrhoeae h041 strain', Journal of Antimicrobial Chemotherapy, vol. 67, pp. 902 - 905, http://dx.doi.org/10.1093/jac/dkr549

Lahra MM, 2012, 'Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010.', Communicable diseases intelligence quarterly report, vol. 36, pp. 95 - 100

Saab J; Bell SM; Lahra MM, 2012, 'Vaginal carriage rate of streptococcal pyogenes in 1600 pregnant women', PATHOLOGY, vol. 44, pp. 567 - 568, http://dx.doi.org/10.1097/PAT.0b013e3283582983

Saab J; Bell SM; Lahra MM, 2012, 'Vaginal carriage rate of streptococcal pyogenes in 1600 pregnant women', Pathology, vol. 44, pp. 567 - 568, http://dx.doi.org/10.1097/PAT.0b013e3283582983

Unemo M; Golparian D; Limnios A; Whiley D; Ohnishi M; Lahra MM; Tapsall JW, 2012, 'In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: Ertapenem for treatment of gonorrhea?', Antimicrobial Agents and Chemotherapy, vol. 56, pp. 3603 - 3609, http://dx.doi.org/10.1128/AAC.00326-12

Whiley D; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots T, 2012, 'The ticking time bomb: escalating drug resistance in Neisseria gonorrhoeae is a public health disaster in waiting', Journal of Antimicrobial Chemotherapy, vol. 67, pp. 2059 - 2061, http://dx.doi.org/10.1093/jac/dks188

Gordon A; Lahra M; Raynes-Greenow C; Jeffery H, 2011, 'Histological chorioamnionitis is increased at extremes of gestation in stillbirth: A population-based study', Infectious Diseases in Obstetrics and Gynecology, vol. 2011, http://dx.doi.org/10.1155/2011/456728

Lahra M, 2011, 'SURVEILLANCE OF ANTIBIOTICIC RESISTANCE IN NEISSERIA GONORRHOEAE IN THE WHO WESTERN PACIFIC AND SOUTH EAST ASIAN REGIONS, 2009', COMMUNICABLE DISEASES INTELLIGENCE, vol. 35, pp. 2 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213218600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM, 2011, 'Additional reports', COMMUNICABLE DISEASES INTELLIGENCE, vol. 35, pp. 257 - 260, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213220100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM, 2011, 'Australian Gonococcal Surveillance Programme annual report, 2010', COMMUNICABLE DISEASES INTELLIGENCE, vol. 35, pp. 229 - 236, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213220100002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM, 2011, 'Meningococcal surveillance', COMMUNICABLE DISEASES INTELLIGENCE, vol. 35, pp. 261 - 261, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213220100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yin JK; Lahra MM; Iskander M; Lambert SB; Heron L; Nissen MD; Rost L; Murphy J; Sloots TP; Booy R, 2011, 'Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare', Journal of Paediatrics and Child Health, vol. 47, pp. 857 - 862, http://dx.doi.org/10.1111/j.1440-1754.2011.02098.x

Collignon P; Bradbury S; Tapsall J; Lahra M; Limnios A; Hogan T; Mercer J; Porritt R; Southwell P; Bates J; Smith H; Lawrence A; McGregor A; Gardam M; Chamley B; Hogg G; Zaia A; Stevens K; Campbell P; Atlas D; Keil AD, 2010, 'ANNUAL REPORT OF THE AUSTRALIAN MENINGOCOCCAL SURVEILLANCE PROGRAMME, 2009', COMMUNICABLE DISEASES INTELLIGENCE, vol. 34, pp. 291 - 302, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213215700007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra M; Tapsall J, 2010, 'ANNUAL REPORT OF THE AUSTRALIAN GONOCOCCAL SURVEILLANCE PROGRAMME, 2009', COMMUNICABLE DISEASES INTELLIGENCE, vol. 34, pp. 89 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213215200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra M; Tapsall J, 2010, 'Gonococcal surveillance', COMMUNICABLE DISEASES INTELLIGENCE, vol. 34, pp. 369 - 370, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213215700018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM; Beeby PJ; Jeffery HE, 2009, 'Intrauterine inflammation, neonatal sepsis, and chronic lung disease: A 13-year hospital cohort study', Pediatrics, vol. 123, pp. 1314 - 1319, http://dx.doi.org/10.1542/peds.2008-0656

Lahra MM; Beeby PJ; Jeffery HE, 2009, 'Maternal versus fetal inflammation and respiratory distress syndrome: A 10-year hospital cohort study', Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 94, http://dx.doi.org/10.1136/adc.2007.135889

Lahra MM, 2008, 'Intrauterine infection: preterm birth and pulmonary impact', MICROBIOLOGY AUSTRALIA, vol. 29, pp. 217 - 219, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000216277300017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Best EJ; Lahra MM; Palasanthiran P, 2005, 'An unusual neonatal zoonosis [1]', Medical Journal of Australia, vol. 182, pp. 137, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06619.x

Lahra MM; Robertson PW; Whybin R; Tapsall JW, 2005, 'Enhanced serological diagnosis of invasive meningococcal disease by determining anti-group C capsule IgM antibody by enzyme immunoassay', Pathology, vol. 37, pp. 239 - 241, http://dx.doi.org/10.1080/00313020500098983

Lahra MM; Jeffery HE, 2004, 'A fetal response to chorioamnionitis is associated with early survival after preterm birth', American Journal of Obstetrics and Gynecology, vol. 190, pp. 147 - 151, http://dx.doi.org/10.1016/j.ajog.2003.07.012

Nolan MA; Craig ME; Lahra MM; Rawlinson WD; Prager PC; Williams GD; Bye AM; Andrews PI, 2003, 'Survival after pulmonary edema due to enterovirus 71 encephalitis', Neurology, vol. 60, pp. 1651 - 1656, http://dx.doi.org/10.1212/01.WNL.0000066810.62490.FF

Bolton P; Mira M; Kennedy P; Lahra MM, 1998, 'The quality of communication between hospitals and general practitioners: an assessment.', J Qual Clin Pract, vol. 18, pp. 241 - 247, http://dx.doi.org/10.1046/j.1440-1762.1998.00281.x

Jeffery HE; Lahra MM, 1998, 'Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers', PEDIATRICS, vol. 101, http://dx.doi.org/10.1542/peds.101.1.e2

Jeffery HE; Lahra MM, 1998, 'Neonatal Outcomes Eight Years After Universal Screening and Non-selective Intrapartum Antibiotics for Maternal Group B Streptococcal Carriers 1451', Pediatric Research, vol. 43, pp. 248 - 248, http://dx.doi.org/10.1203/00006450-199804001-01472

Duan Q; Carmody C; Donovan B; Guy RJ; Hui BB; Kaldor JM; Lahra MM; Law MG; Lewis DA; Maley M; McGregor S; McNulty A; Selvey C; Templeton DJ; Whiley DM; Regan DG; Wood JG, 2021, Modelling outbreak response strategies for preventing spread of emergent Neisseria gonorrhoeae strains in men who have sex with men in Australia, http://dx.doi.org/10.1101/2021.04.30.21256375

Cabrera-Aguas M; Lahra MM; Khoo P; Watson S, 2019, 'The Keratitis Anti-microbial Resistance Surveillance Program (KARSP): Results from 2017-2018', in CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, WILEY, pp. 93 - 94, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493279000135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM; Enriquez RP, 2019, Australian Gonococcal Surveillance Programme, 1 January to 31 March 2018, http://dx.doi.org/10.33321/cdi.2019.43.27

Lahra MM; Enriquez RP, 2019, Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2018, http://dx.doi.org/10.33321/cdi.2019.43.63

Lahra MM; Enriquez RP, 2019, Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2018, http://dx.doi.org/10.33321/cdi.2019.43.60

Lahra MM; Enriquez RP, 2019, Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2018, http://dx.doi.org/10.33321/cdi.2019.43.59

Lahra MM; Enriquez RP; George CRR, 2019, 'Australian Meningococcal Surveillance Programme annual report, 2017', in Communicable diseases intelligence (2018), AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING, Vol. 43, pp. E190 - E190, http://dx.doi.org/10.33321/cdi.2019.43.66

Lahra MM; Enriquez RP; George CRR, 2019, Australian Gonococcal Surveillance Programme, 1 July to 30 September 2018, http://dx.doi.org/10.33321/cdi.2019.43.19

Watson SL; Lahra M; Khoo P; Cabrera-Aguas M, 2018, 'Causative organisms and antibiotic resistance for microbial keratitis in a quaternary referral eye hospital, Sydney Australia over 5 years', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, HI, Honolulu, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), HI, Honolulu, 29 April 2018 - 03 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000442932801210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Buckley C; Forde BM; Trembizki E; Lahra MM; Beatson SA; Whiley DM, 2017, Use of whole genome sequencing to investigate an outbreak of gonorrhoea among females in urban New South Wales, Australia, 2012 to 2014, http://dx.doi.org/10.1101/175869

Cabrera-Aguas M; Lahra M; Khoo P; Pratama R; Gatus B; Gulholm T; El-Nasser J; Watson S, 2017, 'ESTABLISHMENT OF A BACTERIAL KERATITIS SURVEILLANCE PROGRAM IN A TERTIARY REFERRAL HOSPITAL', in CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, WILEY, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413690300056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM; Enriquez RP, 2017, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
', in Communicable diseases intelligence quarterly report, Vol. 41, pp. E109 - E110

Bissessor M; Whiley DM; Lee DM; Snow AF; Fairley CK; Bradshaw CS; Hocking JS; Lahra M; Peel J; Chen MY, 2015, 'FACTORS INFLUENCING THE DETECTION OF NEISSERIA GONORRHOEAE FROM THE TONSILS AND POSTERIOR OROPHARYNX', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A124 - A125, http://dx.doi.org/10.1136/sextrans-2015-052270.328

Hui B; Ryder N; Su J-Y; Ward J; Chen M; Donovan B; Fairley C; Guy R; Lahra M; Law M; Whiley D; Regan D, 2015, 'EXPLORING THE BENEFITS OF MOLECULAR TESTING FOR GONORRHOEA ANTIBIOTIC RESISTANCE SURVEILLANCE IN REMOTE SETTINGS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A27 - A27, http://dx.doi.org/10.1136/sextrans-2015-052270.84

Pillay A; Chi CH; Kwakye C; Danavall D; Taleo F; Katz S; Lahra M; Tun Y; Ballard RC; Asiedu K; Chen CY, 2015, 'NEW DIAGNOSTICS FOR SYPHILIS AND YAWS AND DETECTION OF HAEMOPHILUS DUCREYI IN CUTANEOUS LESIONS IN CHILDREN', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A10 - A10, http://dx.doi.org/10.1136/sextrans-2015-052270.32

Trembizki E; Regan DG; Donovan B; Chen MY; Guy RJ; Lahra MM; Whiley D, 2015, 'AN AUSTRALIA-WIDE MOLECULAR STUDY OF NEISSERIA GONORRHOEAE IDENTIFIES FREQUENT OCCURRENCE OF A KEY CEPHALOSPORIN RESISTANCE MECHANISM', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A26 - A27, http://dx.doi.org/10.1136/sextrans-2015-052270.83

Unemo M; Golparian D; Grad Y; Limnios A; Wi T; Lahra M; Harris S, 2015, 'PHENOTYPIC, GENETIC AND GENOMIC CHARACTERISATION OF THE 2015 WHO NEISSERIA GONORRHOEAE REFERENCE STRAINS FOR QUALITY ASSURANCE OF LABORATORY INVESTIGATIONS GLOBALLY', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A111 - A111, http://dx.doi.org/10.1136/sextrans-2015-052270.295

Tabrizi SN; Twin J; Unemo M; Wiezer A; Limnios A; Lahra M; Garland S, 2013, 'PRELIMINARY ANALYTICAL EVALUATION OF ARTUS (R) CT/NG, FOR SIMULTANEOUS DETECTION OF NEISSERIA GONORRHOEAE AND CHLAMYDIA TRACHOMATIS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A354 - A355, http://dx.doi.org/10.1136/sextrans-2013-051184.1108

Trembizki E; Chen M; Donovan B; Fairley C; Guy RJ; Kaldor JM; Lahra MM; Regan DG; Ward J; Whiley D, 2013, 'A NATIONAL STUDY UTILISING THE SEQUENOM MASSARRAY IPLEX PLATFORM FOR HIGH THROUGHPUT MLST-BASED TYPING AND CHARACTERISATION OF RESISTANCE MECHANISMS IN NEISSERIA GONORRHOEAE', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A80 - A80, http://dx.doi.org/10.1136/sextrans-2013-051184.0242

Trembizki E; Lahra MM; Stevens S; Freeman K; Hogg G; Lawrence A; Pearson J; Smith H; Sloots T; Whiley D, 2013, 'A NATIONAL QUALITY ASSURANCE SURVEY: LOW NEISSERIA GONORRHOEAE MISIDENTIFICATION RATES IN AUSTRALIA, 2012', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A97 - A97, http://dx.doi.org/10.1136/sextrans-2013-051184.0297

Whiley D; Chen M; Donovan B; Fairley C; Guy R; Kaldor J; Regan D; Trembizki E; Ward J; Lahra M, 2013, 'MOLECULAR DETECTION OF ANTIMICROBIAL RESISTANCE IN STI PATHOGENS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A15 - A16, http://dx.doi.org/10.1136/sextrans-2013-051184.0047

Tapsall JW, 2010, Annual report of the Australian Meningococcal Surveillance Programme, 2009, Australian Government Department of Health and Ageing, Canberra, Volume 34 No 3 - September 2010, http://www.health.gov.au/internet/main/publishing.nsf/content/cda-cdi3403g.htm

Tapsall JW, 2009, Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, Australian Government Department of Health and Ageing, Canberra

Lahra MM; Gordon A; Jeffery HE, 2007, 'Chorioamnionitis and fetal response in stillbirth', in American Journal of Obstetrics and Gynecology, pp. 229.e1 - 229.e4, http://dx.doi.org/10.1016/j.ajog.2006.10.900